FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccines | Novartis | pandemic flu | MF59

Novartis: Data supports pre-pandemic vaccinations

Tools

Novartis is touting new data showing that a single jab of one of its vaccines induced a protective antibody response in patients who had already been vaccinated as much as six years earlier. The study examined the effect of its MF59-adjuvanted booster vaccine against H5N1, which many fear could trigger a pandemic.

"These results potentially provide a rationale to prevent pandemic influenza by proactively immunizing the public with stockpiled pre-pandemic vaccines containing MF59," said lead investigator Iain Stephenson.

- read Novartis' release

Related Articles:
New H7 bird flu strain hikes risk of pandemic
Vaccine a success for human-to-human H5N1 case


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Novartis   pandemic flu   MF59   Vaccines  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.